Samsung Biologics Co.,Ltd. (207940.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 1,407,000.00

From 52W high−28.96%

Volume41598.00

Market capKRW 64.55T

P/E (TTM)32.5x

P/S (TTM)14.2x

Div yield—

Key dataSep 18, 2026

Open

KRW 1,407,000.00

From 52W high

−28.96%

Volume

41598.00

Market cap

KRW 64.55T

ValuationView details →

P/E (Fwd)

30.7x

EV/EBITDA

21.5x

P/E (TTM)

32.5x

RSI (14)

37.4

MomentumView details →

1D Return

−0.92%

YTD Return

−17.52%

ValuationView details →

P/E (Fwd)

30.7x

P/E (TTM)

32.5x

EV/EBITDA

21.5x

EV/Sales

14.0x

P/S (TTM)

14.2x

P/B (TTM)

7.7x

ProfitabilityView details →

Gross Margin

55.54%

Net Margin

43.64%

EBITDA Margin

64.97%

ROE (TTM)

23.73%

ROA (TTM)

15.68%

Asset Turnover

0.37x

GrowthView details →

Revenue YoY

−9.64%

EPS YoY

+54.40%

FCF YoY

+293.08%

Revenue CAGR 3Y

+14.94%

EPS CAGR 3Y

+29.93%

EBITDA YoY

+31.89%

MomentumView details →

1D Return

−0.92%

YTD Return

−17.52%

1Y Return

−11.21%

RSI (14)

37.4

vs 50D SMA

−5.40%

vs 200D SMA

−10.36%

Capital & dividendView details →

Debt/Equity

0.15x

Current Ratio

1.80x

Quick Ratio

1.01x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

KRW 9,304.19

EPS Surprise

−3.93%

Beats (12Q)

0/12

Next Q EPS Est

KRW 9,978.26

Avg Surprise (4Q)

−3.93%

Rev Surprise

0.85%

Financials snapshotView financials →

Revenue (TTM)

4.55T

Net Income (TTM)

1.98T

Op. CF (TTM)

2.43T

Next earningsOct 27, 2026 →

Latest newsMore news →

No recent news for 207940.KS.

Similar companies

Celltrion, Inc.068270.KS ALTEOGEN Inc.196170.KQ Samsung Epis Holdings0126Z0.KS SK Biopharmaceuticals Co., Ltd.326030.KS HLB Co., Ltd.028300.KQ PharmaResearch Co., Ltd.214450.KQ Find similar companies →

Latest newsMore news →

No recent news for 207940.KS.